NCT07007559
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07007559
Title ASPEN-09: A Study of Evorpacept in Combination With Anti-cancer Therapies in Advanced / Metastatic Malignancies (ASPEN-09)
Acronym ASPEN-09
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ALX Oncology Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Arizona Cancer Center - North Campus RECRUITING Tucson Arizona 85719 United States Details
Saint Joseph Hospital - Cancer Centers of Colorado RECRUITING Denver Colorado 80218 United States Details
Lutheran Hospital - Cancer Centers of Colorado RECRUITING Golden Colorado 80401 United States Details
Saint Mary's Regional Hospital - Cancer Centers of Colorado RECRUITING Grand Junction Colorado 81501 United States Details
The George Washington Medical facility Associates RECRUITING Washington D.C. District of Columbia 20037 United States Details
University of Michigan Rogel Cancer Center RECRUITING Ann Arbor Michigan 48109 United States Details
HealthPartners Frauenshuh Cancer Center RECRUITING Saint Louis Park Minnesota 55426 United States Details
Oncology Hematology West, Pc Dba Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Gabrail Cancer Center RECRUITING Canton Ohio 44718 United States Details
University of Texas Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
The University of Texas M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field